Background: The volume effect in pancreatic surgery is well established. Regionalization to high-
Introduction
Pancreatic resections are technically complex procedures with high post-operative morbidity and mortality rates. Patient outcomes have improved with time. Numerous studies have addressed factors contributing to improved patient outcomes. Pancreatic resection at a centre with a large number of similar cases performed annually is associated with improved patient outcomes. The myriad explanations for this difference are still being identified. As more pancreatic resections are performed at highvolume centres, the characteristics of patients who receive referral to and treatment at high-volume centres are not well established.
Glasgow and Mulvihill initially described lower mortality among pancreatic cancer patients resected at high-volume centres, supporting regionalization of the care of these patients. 1, 2 The advantage of a high-volume centre resection was found to extend to non-oncological pancreatic resections and other major cancer surgery. 3, 4 For all pancreatic resections, a high-volume centre resection is associated with shorter length of stay in addi-tion to improved mortality. 5 These superior outcomes for a pancreatic resection extend to international practice settings. [6] [7] [8] For cancer care, the benefits of a high-volume centre resection include lengthened long-term survival beyond improvements in immediate post-operative results. [9] [10] [11] [12] The factors influencing pancreatic resection outcomes are complex and numerous. In addition to hospital volume, high individual surgeon volume is associated with improved mortality. [13] [14] [15] Patient sociodemographic factors and comorbidities influence outcomes and whether potentially curative resections are even pursued. 16 This study addresses trends in hospital volume status in a recent, national dataset of patients undergoing a pancreatic resection. Predictors of a resection at a high-volume centre are identified.
Patients and methods
This study is a retrospective review of data from the Nationwide Inpatient Sample (NIS). The NIS is an administrative database assembled by the Healthcare Cost and Utilization Project (HCUP), part of the Agency for Healthcare Research and Quality (AHRQ). NIS includes a sampling of nationwide short-term, nonFederal hospitals, representing approximately 8 000 000 admissions annually and 40 000 000 weighted admissions annually. 17 Admission diagnosis and procedure codes from 2004 to 2011 were queried. Admission records were included in the analysis if an ICD-9 procedure code for a pancreatic resection was utilized. Pancreatic resection procedures were total pancreatectomy (52.6), radial pancreaticoduodenectomy (52.7) and partial pancreatectomy (52.51, proximal pancreatectomy; 52.52, distal pancreatectomy; 52.53, radical subtotal pancreatectomy; 52.59, other partial pancreatectomy).
Patient characteristics collected included age, gender, race, payer type and Elixhauser Total score, generated using the HCUP Comorbidity Software, Version 3.7.
18 Admission characteristics collected included pancreatic diagnosis and malignancy status, urgency of admission (elective or non-elective), year and procedure performed, as classified above. Hospital characteristics collected included bed size (small, medium or large), teaching status, location (rural or urban) and region (Northeast, Midwest, South or West). Average annual pancreatic resection volumes were calculated for each centre. Based on categories previously established in the literature, centres were divided into low-(less than 5 resections annually), medium-(5 to 18 resections annually) and high-(greater than 18 resections annually) volume categories. 19, 20 A sensitivity analysis was performed to identify very high-volume centres with cutoffs of 50, 75, 100 and 200 annual pancreatic resections. Admission outcomes collected were inpatient mortality, length of stay and inpatient morbidity. Morbidity was established using secondary diagnosis codes or procedure codes and included the following categories of diagnoses: infectious, respiratory, cardiac, wound complications, thromboembolic, perforation and gastrointestinal bleeding or ulceration.
All statistical analyses were performed using the designweighted survey procedures in SAS (version 9.3; SAS Institute, Cary, NC, USA). For all analyses, a P-value of <0.05 was considered statistically significant. All values reported were based on nationally weighted admissions.
Continuous variables, age and Elixhauser Total score were categorized to enhance clinical relevance. Race and payer categories with a small number of patients were collapsed into aggregate groups. Patient, admission and hospital characteristics by hospital volume status were compared using the chi-square test. Mortality and morbidity were compared by hospital volume status using the chi-square test. Length of stay was non-normal and reported as median with interquartile range; lengths of stay were compared by hospital volume status using the surveyreg for sample survey data analysis. The distribution of resections at low-, medium-and high-volume centres over years was assessed using a CochranArmitage test of trends. Sub-group analyses of mortality, complications and length of stay were performed for elective and nonelective admissions.
A survey-weight multivariable logistic regression was performed to identify predictors of resection at a high-volume centre compared with a low-or medium-volume centre. A univariate screen was performed using the chi-square testing. Model building prioritized confounding over co-linearity. Variables considered for possible inclusion in the final model were age, gender, race, payer type, Elixhauser Total, pancreatic diagnosis, malignancy status, urgency of admission, year, procedure performed, bed size, teaching status, location and region. Table 1 .
Results

Patient demographics
Univariate analysis
Patients greater than or equal to 70 years of age were more common at low-volume hospitals compared with high-volume hospitals, but this finding was not statistically significant (4920, 33.1% versus 26 187, 30.4%; P = 0.178). Patients with Elixhauser Totals of three or greater were less common among high-volume compared with low-volume centres (32 103, 37.2% versus 6146, 41.3%, P = 0.001). Patients of white race were more common at high-volume centres compared with low-volume centres (56 585, 65.6% versus 7988, 53.7%, P = 0.018). A private payment source was less common at low-volume centres compared with highvolume centres (5481, 36.9% versus 37 663, 43.7%; P < 0.001). These demographic disparities persist when examining very highvolume centres.
Resections at high-volume centres were more often performed for malignant conditions than at low-volume centres (53 670, 62.2% versus 8325, 56.0%; P = 0.001). The majority of resections at high-volume centres were radical pancreaticoduodenectomies (48 546, 56.3%) whereas the majority of resections at low-volume centres were partial pancreatectomies (8881, 59.7%; P < 0.001). A larger percentage of low-volume resections occurred during nonelective admissions (5779, 38.9% versus 15 275 17.7%; <0.001). For very high-volume centres, the percentage of resections that occurred during non-elective admissions were 16.2%, 12.6%, 11.6% and 8.5%, respectively, for centres with annual volumes of greater than or equal to 50, 75, 100 and 200. High-volume centre resections were largely performed at urban (84 988, 98.6%) and teaching (82 821, 96.0%) facilities with a large bed size (77 873, 90.3%).
Patient outcomes
The overall mortality rate was 4.3% (5603). Those resected at high-volume centres experienced lower mortality rates (P < 0.001), lower complication rates (P < 0.001) and shorter median lengths of stay (P < 0.001) as displayed in Table 2 . Among patients resected during non-elective admissions, mortality rates were 12.8% (740) at low-volume centres compared with 6.8% (1031) at high-volume centres (P < 0.001). Complication rates were 57.1% (3298) at low-volume centres compared with 47.5% (7259) at high-volume centres. Outcomes for resections performed during elective and non-elective admissions are displayed in Fig. 1 . Mortality and complication rates among patients resected a very high-volume centres decreased as the volume threshold increased. At centres performing 50 or more resections annually, complication and mortality rates were 31.6% (18 591) and 2.8% (1634) compared with 39.7% (28 068) and 5.6% (3969) at other centres (both P < 0.001). At centres performing 75 or more resections annually, complication and mortality rates were 30.0% (11 124) and 2.7% (999) compared with 38.4% (35 535) and 5.0% (4604) at other centres (both P < 0.001). At centres performing 100 or more resections annually, complication and mortality rates were 29.4% (7763) and 2.5% (649) compared with 37.7% (38 896) and 4.8% (4954) at other centres (both P < 0.001). At centres performing 200 or more resections annually, complication and mortality rates were 26.9% (3709) and 2.1% (288) compared with 37.1% (42 950) and 4.6% (5315) at other centres (complications P = 0.001, mortality P < 0.001).
Multivariate analysis
The multivariable logistic regression model predicting resection at a high-volume centre compared with a low-or medium-volume centre included age, gender, race, Elixhauser Total, payer, urgency of admission, diagnosis and procedure type. Unadjusted and adjusted odds ratios (ORs) for the predictors are in Table 3 and 
Discussion
This study examined trends in high-volume centre pancreatic resections nationally from 2004 to 2011. Patients resected at highvolume centres experienced less morbidity and mortality as well as shorter median length of stay. Morbidity and mortality rates were lower at very high volume centres, with rates decreasing as the annual volume threshold increased. Over time, an increasing percentage of patients were resected at high-volume centres. There remain demographic discrepancies between patients undergoing a resection at high-volume centres compared with low-or mediumvolume centres. After adjustment, predictors of not undergoing a resection at a high-volume centre were Elixhauser Total of three or greater, non-elective admission status, resection for a nonpancreatic and non-duodenal malignant neoplasm, black race and age over 50 years, suggesting that patients who are predisposed to Although resection at high-volume hospitals has an established association with improved patient outcomes, who receives referral to these centres and why remains less well explained. Patients undergoing complex oncological resections at low-volume centres are more likely to be non-white, without private insurance, undergoing emergent admission and have a high number of comorbidities. [21] [22] [23] [24] Those who undergo a high-volume centre resection have lower mortality rates and shorter length of stay. [1] [2] [3] [4] [5] Even in locations with multiple high-volume centres, such as New York City, non-white patients are still more likely to receive a resection at a low-volume centre. 25 When a resection occurs at a rural hospital for select high-risk operations, it is unlikely to occur at a high-volume centre, suggesting a further need for regionalization of complex procedures. 26 This regionalization for rural patients undergoing a pancreatic resection would often increase patient travel time. 27 Findings from this study are consistent with earlier publications. The vast majority of resections occurred in high-volume centres, suggesting that regionalization has been widely accepted and most patients are benefiting from the volume effect. However, in spite of this progress there are still significant disparities in which patients undergo a resection at high-volume centres and benefit from the volume effect.
The utilization of the NIS, an administrative database, creates several limitations for this analysis. Clinical details that may influence patient outcomes or reasons for referral are not available. Similarly, limited information about the individual patients prevents analysis of long-term outcomes or geographical factors that may influence referral to high-volume centres. Because of the large population analyzed, small differences in patient characteristics and outcomes may be statistically significant, but not clinically meaningful.
In spite of these limitations, this study identifies unequal referrals to high-volume centres even in the setting of widespread regionalization. Those patients who are not receiving care at highvolume centres do not benefit from the improved outcomes owing to surgeon experience, established care pathways, and hospital staffing and infrastructure to support frequent complex surgical procedures. Low-volume centres resect a disproportionately large number of patients who fall into groups with historically worse post-operative outcomes at baseline. A portion of the superior outcomes found at high-volume centres may be because of selective referral of patients who are predisposed to do well, whereas those patients who are less desirable surgical candidates remain at local, low-volume centres for resection.
Research regarding patterns of regionalization is necessary to further understand why some patient populations do not receive the benefit of a resection at a high-volume centre. Understanding geographical and referral network barriers will allow surgeons, and referring physicians, to identify patients who may not already seek pancreatic surgery at high-volume centres.
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